477a A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMISUC, COHORT 1
| Autor: | Sands, Bruce E., Peyrin-Biroulet, Laurent, Danese, Silvio, Rubin, David T., Vermeire, Severine, Ma, Christopher, Ritter, Timothy, Panaccione, Remo, Feagan, Brian G., Mcgovern, Dermot P.B., Laurent, Olivier, Luo, Allison, Nguyen, Deanna D., Lu, JD, Wiechowska-Kozlowska, Anna, Leszczyszyn, Jaroslaw, Kempinski, Radoslaw, Kierkus, Jaroslaw, Targan, Stephan |
|---|---|
| Zdroj: | In Gastroenterology May 2023 164(6) Supplement:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|